scholarly journals Role of nuclear and cytoplasmic localization in the tumour-suppressor activity of the von Hippel-Lindau protein

Oncogene ◽  
2003 ◽  
Vol 22 (26) ◽  
pp. 3992-3997 ◽  
Author(s):  
Martin D Lewis ◽  
Ben J Roberts
2006 ◽  
Vol 8 (7) ◽  
pp. 688-698 ◽  
Author(s):  
Chengyu Liang ◽  
Pinghui Feng ◽  
Bonsu Ku ◽  
Iris Dotan ◽  
Dan Canaani ◽  
...  

2021 ◽  
Author(s):  
Xingcheng Xiong ◽  
Juanli Xi ◽  
Qian Liu ◽  
Cixiao Wang ◽  
Zeyou Jiang ◽  
...  

2010 ◽  
Vol 12 (7) ◽  
pp. 665-675 ◽  
Author(s):  
Ying Zhao ◽  
Jing Yang ◽  
Wenjuan Liao ◽  
Xiangyu Liu ◽  
Hui Zhang ◽  
...  

2002 ◽  
Vol 2 ◽  
pp. 1885-1890 ◽  
Author(s):  
Mirna Mourtada-Maarabouni ◽  
Gwyn T. Williams

The candidate tumour suppressor gene, LUCA-15, maps to the lung cancer tumour suppressor locus 3p21.3. The LUCA-15 gene locus encodes at least four alternatively spliced transcripts, which have been shown to function as regulators of apoptosis, a fact that may have a major significance in tumour regulation. This review highlights evidence that implicates the LUCA-15 locus in the control of apoptosis and cell proliferation, and reports observations that significantly strengthen the case for tumour suppressor activity by this gene.


2001 ◽  
Vol 6 (3) ◽  
pp. 237-247 ◽  
Author(s):  
Takashi Kohda ◽  
Akio Asai ◽  
Yoshimi Kuroiwa ◽  
Shin Kobayashi ◽  
Kohzoh Aisaka ◽  
...  

Author(s):  
Cameron Snell ◽  
Kevin C. Gatter ◽  
Adrian L. Harris ◽  
Francesco Pezzella

This chapter covers the relationship between cancer and metabolism. It discusses the role of angiogenesis and metabolic reprogramming in influencing tumour growth. The transcription factors that orchestrate the metabolic switch are discussed. The chapter presents an overview of the contribution of tumour suppressors to increased glycolysis. The metabolic changes that support uncontrolled proliferation such as lactate and pH levels, hypoxia, and reactive oxygen species are discussed. The chapter also covers the contribution of metabolic genes with oncogenic or tumour suppressor activity to metabolic transformation, the upregulation of lipid biosynthesis in cancer, and glycogen synthesis in cancer. The chapter concludes with a description of the potential strategies for targeting metabolic transformation.


2010 ◽  
Vol 8 (5) ◽  
pp. 115
Author(s):  
P. Monfared ◽  
D. Rudan ◽  
L. Franken ◽  
G. Schneider ◽  
T. Viel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document